Nitric oxide mediates abnormal responsiveness of thyroid arteries in methimazole-treated patients

European Journal of Endocrinology

Volumn 152, Issue 4, 2005, Pages 551-556

  Ortega, Joaquín ^a   Vila, José M ^a   Mauricio, María Dolores ^a   Segarra, Gloria ^a   Medina, Pascual ^a   Martínez León, Juan B ^a   Lluch, Salvador ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; APAMIN; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; INDOMETACIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; POTASSIUM CHANNEL; POTASSIUM ION; PROSTACYCLIN; THIAMAZOLE;

ADULT; ARTERY; ARTERY DILATATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; GRAVES DISEASE; HUMAN; HUMAN TISSUE; INHIBITION KINETICS; MALE; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; THYROID GLAND; THYROIDECTOMY;

ACETYLCHOLINE; ADULT; ANTITHYROID AGENTS; APAMIN; ARTERIES; BIOLOGICAL FACTORS; CALCIUM; CHARYBDOTOXIN; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; METHIMAZOLE; MIDDLE AGED; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; THYROID GLAND;

EID: 17744382394     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01889     Document Type: Article

References (25)

1. Klein I & Ojamaa K. Thyroid hormone and the cardiovascular system. New England Journal of Medicine 2001 344 501-509.
2. Scivoletto R, Fortes ZB & Garcia-Leme J. Thyroid hormones and vascular reactivity: role of the endothelial cell. European Journal of Pharmacology 1986 129 271-278.
3. Gunasekera RD & Kuriyama H. The influence of thyroid states upon responses of the rat aorta to catecholamines. British Journal of Pharmacology 1990 99 541-547.
4. McAllister RM, Grossenburg VD, Delp MD & Laughlin MH. Effects of hyperthyroidism on vascular contractile and relaxation responses. American Journal of Physiology 1998 274 E946-E953.
5. Bussemaker E, Popp R, Fisslthaler B, Larson CM, Fleming I, Busse R & Brandes RP. Hyperthyroidism enhances endothelium-dependent relaxation in the rat renal artery. Cardiovascular Research 2003 59 181-188.
6. Napoli R, Biondi B, Guardasole V, Matarazzo M, Pardo F, Angelini V, Fazio S & Sacca L. Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation 2001 104 3076-3080.
7. Torondel B, Vila JM, Segarra G, Lluch P, Medina P, Martinez-Leon J, Ortega J & Lluch S. Endothelium-dependent responses in human isolated thyroid arteries from donors. Journal of Endocrinology 2004 181 379-384.
8. Feletou M & Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. British Journal of Pharmacology 1988 93 515-524.
9. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998 396 269-272.
10. Campbell WB, Gebremedhin D, Pratt PF & Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circulation Research 1996 78 415-423.
11. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H & Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. Journal of Clinical Investigation 2000 106 1521-1530.
12. Chauhaii SD, Nilsson H, Ahluwalia A & Hobbs AJ. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. PNAS 2003 100 1426-1431.
13. Archer SL, Gragasin FS, Wu X, Wang S, McMurtry S, Kim DH, Platonov M, Koshal A, Hashimoto K, Campbell WB, Falck JR & Michelakis ED. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BKCa channels. Circulation 2003 107 769-776.
14. Kedderis GL & Rickert DE. Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase. Drug Metabolism and Disposition 1985 13 58-61.
15. Guo Z, Raeissi S, White RB & Stevens JC. Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. Drug Metabolism and Disposition 1997 25 390-393.
16. Huang SM, Chow NH, Lee HL & Wu TJ. The value of color flow Doppler ultrasonography of the superior thyroid artery in the surgical management of Graves' disease. Archives of Surgery 2003 138 146-151.
17. Castagnone D, Rivolta R, Rescalli S, Baldini MI, Tozzi R & Cantalamessa L. Color Doppler sonography in Graves' disease: value in assessing activity of disease and predicting outcome. American Journal of Roentgenology 1996 166 203-207.
18. Nagura S, Katoh R, Miyagi E, Shibuya M & Kawaoi A. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves' disease possibly correlated with increased vascular density. Human Pathology 2001 32 10-17.
19. Colin IM, Kopp P, Zbaren J, Haberli A, Grizzle WE & Jameson JL. Expression of nitric oxide synthase III in human thyroid follicular cells: evidence for increased expression in hyperthyroidism. European Journal of Endocrinology 1997 136 649-655.
20. Busse R & Fleming I. Pulsatile stretch and shear stress: physical stimuli determining the production of endothelium-derived relaxing factors. Journal of Vascular Research 1998 35 73-84.
21. Hoger JH, Ilyin VI, Forsyth S & Hoger A. Shear stress regulates the endothelial Kir2.1 ion channel. PNAS 2002 99 7780-7785.
22. Angus JA, Cocks TM & Satoh K. The alpha adrenoceptors on endothelial cells. Federation Proceedings 1986 45 2355-2359.
23. Dora KA, Doyle MP & Duling BR. Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles. PNAS 1997 94 6529-6534.
24. Dora KA, Hinton JM, Walker SD & Garland CJ. An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery British Journal of Pharmacology 2000 129 381-387.
25. Paschke R, Vogg M, Kristoferitsch R, Aktuna D, Wawschinek O, Eber O & Usadel KH. Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease. Journal of Clinical Endocrinology and Metabolism 1995 80 2470-2474.